GE HealthCare (GEHC) stock
NASDAQ
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $37.5B
- As of Nov 13, 2026
- P/E
- 17.43x
- Trailing twelve months
- P/B
- 3.23x
- Latest reported equity
- P/S
- 1.73x
- Trailing twelve months
- ROE
- 18.5%
- Trailing twelve months
- Dividend yield
- 0.17%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $37.5B
- As of Nov 13, 2026
- P/E
- 17.43x
- Trailing twelve months
- P/B
- 3.23x
- Latest reported equity
- P/S
- 1.73x
- Trailing twelve months
- ROE
- 18.5%
- Trailing twelve months
- Dividend yield
- 0.17%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
17.43x
P/B
3.23x
P/S
1.73x
Earnings and dividend metrics▾
Earnings
EPS
$4.76
Earnings per share
BPS
$25.69
Book value per share
ROE
18.5%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $4.76 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $25.69 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 18.5%.
Dividends
Yield
0.17%
Dividend per share
$0.14
Payout ratio
3.0%
Consecutive years
1+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $14.00 before tax.
- Payout ratio — 3.0% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 1 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 7.2% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $5.14B+7.2%
$4.86B
Jul–Sep '24
$5.14B
Jul–Sep '25
$5.51B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 28, 2026.
- Earnings per share increased 38.8% from the same quarter a year earlier.
- Revenue increased 7.2% from the same quarter a year earlier.
- Operating income increased 23.3% from the same quarter a year earlier.
- Net income increased 37.9% from the same quarter a year earlier.
Filed Oct 28, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Grogan William KChief Financial Officer · Sep 14, 2026Grant or award75,096 shares · $0Avg. price $0
Show 2 price lots
- 12,840 shares × $0$0
- 62,256 shares × $0$0
- Arduini Peter JPresident and CEO · Sep 3, 2026Shares withheld for taxes6,303 shares · $445KAvg. price $70.56241,606 shares held after
- Kass-Hout TahaChief Technology Officer · Sep 3, 2026Shares withheld for taxes1,502 shares · $106KAvg. price $70.5688,467 shares held after
- Jimenez Frank RGC & Corporate Secretary · Sep 3, 2026Shares withheld for taxes1,480 shares · $104KAvg. price $70.5689,321 shares held after
- Rackliffe PhilipCEO, AIS · Sep 3, 2026Shares withheld for taxes798 shares · $56KAvg. price $70.5641,533 shares held after
- O'Neill Kevin MichaelCEO, PDx · Sep 3, 2026Shares withheld for taxes718 shares · $51KAvg. price $70.5632,026 shares held after
- Holton Adam YChief People Officer · Sep 3, 2026Shares withheld for taxes673 shares · $47KAvg. price $70.5619,533 shares held after
- Estrampes CatherineChief Commer. & Growth Officer · Sep 3, 2026Shares withheld for taxes508 shares · $36KAvg. price $70.5623,573 shares held after
- Newcomb George A.Chief Accounting Officer · Sep 3, 2026Shares withheld for taxes112 shares · $8KAvg. price $70.5610,515 shares held after
- Arduini Peter JPresident and CEO · Sep 1, 2026Shares withheld for taxes11,515 shares · $820KAvg. price $71.23
Show 2 price lots
- 6,043 shares × $71.23$430K
- 5,472 shares × $71.23$390K
- Jimenez Frank RGC & Corporate Secretary · Sep 1, 2026Shares withheld for taxes3,131 shares · $223KAvg. price $71.23
Show 2 price lots
- 1,751 shares × $71.23$125K
- 1,380 shares × $71.23$98K
- Kass-Hout TahaChief Technology Officer · Sep 1, 2026Shares withheld for taxes2,940 shares · $209KAvg. price $71.23
Show 2 price lots
- 1,644 shares × $71.23$117K
- 1,296 shares × $71.23$92K
- Bankes JeannetteCEO, Patient Care Solutions · Sep 1, 2026Shares withheld for taxes1,064 shares · $76KAvg. price $71.2337,293 shares held after
- Holton Adam YChief People Officer · Sep 1, 2026Shares withheld for taxes659 shares · $47KAvg. price $71.2320,206 shares held after
- Rackliffe PhilipCEO, AIS · Sep 1, 2026Shares withheld for taxes856 shares · $61KAvg. price $71.23
Show 3 price lots
- 340 shares × $71.23$24K
- 290 shares × $71.23$21K
- 226 shares × $71.23$16K
- Holton Adam YChief People Officer · Aug 15, 2026Shares withheld for taxes1,360 shares · $100KAvg. price $73.6920,865 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary10-QThe company said total revenues for the 3 months ended September 30, 2026 were $5,513 million, growing 7.2% as reported and 6.2% organically. Sales of services rose 8.1%.Published Oct 28, 2026 · Filed Oct 28, 2026Read the summary →
- AI summary8-KThe company said revenue for Q3 2026 rose to $5.5 billion, up 7.2%, and that Organic revenue growth* was 6.2%. Net income margin was 11.1%, Adjusted EBIT margin* was 16.6%, and diluted EPS was $1.36.Published Oct 28, 2026 · Filed Oct 28, 2026Read the summary →
- AI summary8-KGE HealthCare said that in the second quarter of Q2 2026, it combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions (AIS), resulting in three reportable segments: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).Published Oct 7, 2026 · Filed Jul 29, 2026Read the summary →
- The company said total revenues for the 3 months ended September 30, 2026 were $5,513 million, growing 7.2% as reported and 6.2% organically. Sales of services rose 8.1%.Read the full analysis →
- The company said revenue for Q3 2026 rose to $5.5 billion, up 7.2%, and that Organic revenue growth* was 6.2%. Net income margin was 11.1%, Adjusted EBIT margin* was 16.6%, and diluted EPS was $1.36.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
GE HealthCare (GEHC) stock information
NASDAQ
GE HealthCare (GEHC) is listed on NASDAQ. Its market capitalization is about $37.5B. On trailing-twelve-month earnings the P/E ratio is 17.43, and the P/B ratio is 3.23. Return on equity is 18.5%. These figures are computed in-house from official filings and are reference information only.
GE HealthCare — frequently asked questions
- What is the P/E ratio of GE HealthCare (GEHC)?
- On a trailing-twelve-month basis, GEHC trades at a P/E ratio of 17.43. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of GE HealthCare?
- GEHC has a market capitalization of about $37.5B. The figure moves with the share price and is refreshed each trading day.
- Does GE HealthCare pay a dividend?
- GEHC has a dividend yield of about 0.17%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.